MaleNCT07894263
2D:4D Ratio vs Semen Parameters
An observational study of Male, run by Suleyman Demirel University at 1 site in Turkey (Türkiye).
Trial summary
The aim of this study evaluate the relationship between sperm count and the second-to-fourth digit ratio (2D:4D) in male patients. Additionally, the associations between body mass index, hormonal profile, hand morphometric measurements, and semen parameters were investigated. Study hypotheses: H1. Read more about this study
- Who is it for?
- Ages 18 years and older, men only
- Conditions the study is for
- Male
- What is being tested?
- Group 1
- How many people
- 22 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 30 Nov 2024to 30 Dec 2025
- How long will I take part?
- 1 Day
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Men only
- No healthy volunteers
- Adult, Older adult
Study population: 22
Who may be able to join
- Male individuals aged 18 years and older
Who cannot join
- Individuals with a history of index or ring finger fractures, finger injuries, arthritis, gout, or rheumatic diseases affecting the hands or fingers,
- who left-handedness,
- who lack of semen analysis
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Süleyman Demirel University
Merkez, Isparta, 32100
About this study
Official title: Relationship Between 2D:4D Finger Ratio and Semen Parameters in Men
The aim of this study evaluate the relationship between sperm count and the second-to-fourth digit ratio (2D:4D) in male patients. Additionally, the associations between body mass index, hormonal profile, hand morphometric measurements, and semen parameters were investigated. Study hypotheses:
H1. There is a significant relationship between the second-to-fourth digit ratio (2D:4D) and sperm count in male patients.
Read more
H2. There is a significant relationship between body mass index (BMI) and semen parameters in male patients.
H3. There is a significant relationship between hormonal profile and semen parameters in male patients.
H4. There is a significant relationship between hand morphometric measurements and semen parameters in male patients.
H5. There is a significant relationship between the second-to-fourth digit ratio (2D:4D) and hormonal profile in male patients.
Read the detailed description
The study was conducted on male individuals who applied to the Suleyman Demirel University Department of Obstetrics and Gynecology. It has been designed as a cross-sectional and prospective study. The parameters to be evaluated in a total of 22 participants (n=22) are: Demographics, BMI, semen parameters, hand measurements, 2D:4D ratios and hormonal data.
- Conditions
- Male
- Being tested
- Group 1
- Keywords
- 2D:4D ratio, hand morphometry, testosterone, semen parameters
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Group 1Other
The study included male individuals aged 18 years and older. Individuals with a history of index or ring finger fractures, finger injuries, arthritis, gout, or rheumatic diseases affecting the hands or fingers, left-handedness, and lack of semen analysis were excluded.All assessments for this group will be conducted by the doctor.Participation rates and measurements were recorded regularly. For each participant,For each participant, BMI, semen parameters, hand measurements, and 2D:4D ratios were evaluated. Hormonal data were also assessed.
| Study group | Role | What they receive |
|---|---|---|
| Male individuals who applied to the Department of Obstetrics and Gynecology | One-time measurements were planned. For each male participant, measurements of the demographics, Body Mass Index (BMI), semen parameters, hand measurements, 2D:4D ratios and hormonal data. Receives: Other: Group 1 |
What is being measured
The primary outcome is the main question the study is designed to answer.
Hand and finger lengths (2d:4d)
Measurements were taken using standardized digital palm photographs taken with the hand placed on a metric surface at a height of 50 cm. The images were analyzed using ImageJ v1.50 software according to international anthropometric protocols (ISAK, WHO, NASA, and the Anthropometric Standardization Reference Guide). Hand length (HL - distance from the wrist crease at the radiocarpal joint to the distal tip of the third finger), hand width (HW - maximum distance between the second and fifth metacarpal heads), wrist width (WW - distance between the radial and ulnar styloid processes), 2D (distance from the metacarpophalangeal crease of the index finger to the fingertip), and 4D (distance from the metacarpophalangeal crease of the ring finger to the fingertip) were measured. The 2D:4D ratio was calculated by dividing the length of the second finger by the length of the fourth finger.
Measured: Baseline (Day 0)
Semen analysis
Semen samples were collected by masturbation after 2-7 days of sexual abstinence using sterile containers and allowed to liquefy for 30 minutes at 37°C. Ejaculate volume (EjVol) was measured in mL by direct volume assessment and classified as hypospermia (<1.5 mL), normo-volume (1.5-5 mL), or hyperspermia (>5 mL). Sperm concentration (SC) was calculated as total sperm count/semen volume and categorized as severe oligozoospermia (<5 million/mL), mild-moderate oligozoospermia (5-15 million/mL), normozoospermia (15-200 million/mL), or polyspermia (>200 million/mL).Total motility (ABC) was defined as the percentage of progressive (A+B) and non-progressive (C) motile sperm and classified as severe asthenozoospermia (<20%), moderate motility impairment (20-39%), borderline normal motility (40-60%), and good motility (>60%). Progressive motility (PM) was evaluated as severe (<10%), reduced (10-31%), normal (32-50%), or good (>50%).
Measured: Baseline (Day 0)
Hormone analysis
Hormone levels were measured by Enzyme-Linked Immunosorbent Assay (ELISA) from fasting venous serum samples, and the relationships between hand/finger lengths and ratios were evaluated.Hormonal evaluation included the examination of folic acid (FA), follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin (PRL), and total testosterone (TT) levels.
Measured: Baseline (Day 0)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Oct 2026
- Study start30 Nov 2024
- Primary completion30 Nov 2025
- Study completion30 Dec 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for MaleStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 22 participants (actual)
- Target duration
- 1 Day
Sponsor and investigators
- Lead sponsor
- Suleyman Demirel University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mine ARGALI DENIZ, Suleyman Demirel University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07894263
- Sponsor's protocol ID
- SuleymanDU-80/13
- Status last verified
- Oct 2026
- First submitted
- 14 Oct 2026
- Last updated
- 26 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: The data for objectives of the research will be compared after they are received.
Study at a glance
From the registry record, last updated by the sponsor on 26 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Relationship Between 2D:4D Finger Ratio and Semen Parameters in Men
- ClinicalTrials.gov ID
- NCT07894263
- Acronym / sponsor ID
- SuleymanDU-80/13
- Conditions
- Male
- Keywords
- 2D:4D ratio, hand morphometry, testosterone, semen parameters
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 22 participants (actual)
- Lead sponsor
- Suleyman Demirel UniversityUniversity, hospital or other
- Study start
- 30 Nov 2024 (actual)
- Primary completion
- 30 Nov 2025 (actual)
- Study completion
- 30 Dec 2025 (actual)
- First posted
- 26 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study evaluate the relationship between sperm count and the second-to-fourth digit ratio (2D:4D) in male patients. Additionally, the associations between body mass index, hormonal profile, hand morphometric measurements, and semen parameters were investigated. Study hypotheses:
H1. There is a significant relationship between the second-to-fourth digit ratio (2D:4D) and sperm count in male patients.
H2. There is a significant relationship between body mass index (BMI) and semen parameters in male patients.
H3. There is a significant relationship between hormonal profile and semen parameters in male patients.
H4. There is a significant relationship between hand morphometric measurements and semen parameters in male patients.
H5. There is a significant relationship between the second-to-fourth digit ratio (2D:4D) and hormonal profile in male patients.
Detailed description
The study was conducted on male individuals who applied to the Suleyman Demirel University Department of Obstetrics and Gynecology. It has been designed as a cross-sectional and prospective study. The parameters to be evaluated in a total of 22 participants (n=22) are: Demographics, BMI, semen parameters, hand measurements, 2D:4D ratios and hormonal data.
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Target follow-up
- 1 Day
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Male individuals who applied to the Department of Obstetrics and Gynecology | – | Other: Group 1One-time measurements were planned. For each male participant, measurements of the demographics, Body Mass Index (BMI), semen parameters, hand measurements, 2D:4D ratios and hormonal data. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- 22
Key inclusion criteria (1 listed)
- Male individuals aged 18 years and older
Key exclusion criteria (3 listed)
- Individuals with a history of index or ring finger fractures, finger injuries, arthritis, gout, or rheumatic diseases affecting the hands or fingers,
- who left-handedness,
- who lack of semen analysis
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Group 1The study included male individuals aged 18 years and older. Individuals with a history of index or ring finger fractures, finger injuries, arthritis, gout, or rheumatic diseases affecting the hands or fingers, left-handedness, and lack of semen analysis were excluded.All assessments for this group will be conducted by the doctor.Participation rates and measurements were recorded regularly. For each participant,For each participant, BMI, semen parameters, hand measurements, and 2D:4D ratios were evaluated. Hormonal data were also assessed. | Other | Male individuals who applied to the Department of Obstetrics and Gynecology |
Primary outcome
Hand and finger lengths (2d:4d)
Time frame: Baseline (Day 0)
Measurements were taken using standardized digital palm photographs taken with the hand placed on a metric surface at a height of 50 cm. The images were analyzed using ImageJ v1.50 software according to international anthropometric protocols (ISAK, WHO, NASA, and the Anthropometric Standardization Reference Guide). Hand length (HL - distance from the wrist crease at the radiocarpal joint to the distal tip of the third finger), hand width (HW - maximum distance between the second and fifth metacarpal heads), wrist width (WW - distance between the radial and ulnar styloid processes), 2D (distance from the metacarpophalangeal crease of the index finger to the fingertip), and 4D (distance from the metacarpophalangeal crease of the ring finger to the fingertip) were measured. The 2D:4D ratio was calculated by dividing the length of the second finger by the length of the fourth finger.
Semen analysis
Time frame: Baseline (Day 0)
Semen samples were collected by masturbation after 2-7 days of sexual abstinence using sterile containers and allowed to liquefy for 30 minutes at 37°C. Ejaculate volume (EjVol) was measured in mL by direct volume assessment and classified as hypospermia (<1.5 mL), normo-volume (1.5-5 mL), or hyperspermia (>5 mL). Sperm concentration (SC) was calculated as total sperm count/semen volume and categorized as severe oligozoospermia (<5 million/mL), mild-moderate oligozoospermia (5-15 million/mL), normozoospermia (15-200 million/mL), or polyspermia (>200 million/mL).Total motility (ABC) was defined as the percentage of progressive (A+B) and non-progressive (C) motile sperm and classified as severe asthenozoospermia (<20%), moderate motility impairment (20-39%), borderline normal motility (40-60%), and good motility (>60%). Progressive motility (PM) was evaluated as severe (<10%), reduced (10-31%), normal (32-50%), or good (>50%).
Hormone analysis
Time frame: Baseline (Day 0)
Hormone levels were measured by Enzyme-Linked Immunosorbent Assay (ELISA) from fasting venous serum samples, and the relationships between hand/finger lengths and ratios were evaluated.Hormonal evaluation included the examination of folic acid (FA), follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin (PRL), and total testosterone (TT) levels.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Oct 2026.
- Individual participant dataSharing planned: No. The data for objectives of the research will be compared after they are received.
Related trials for Male
Active, not recruitingObservational study
A Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns and Outcomes in Atypical Hemolytic Uremic Syndrome Patients
Atypical Hemolytic Uremic Syndrome(aHUS)
Not yet recruitingPhase 2
Effects of Meal Macronutrients on Postprandial Lipids
Nephrotic Syndrome, Lipodystrophy
RecruitingPhase 1/2
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma
RecruitingPhase 3
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma
RecruitingObservational study
Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
Renal Tumor Histology, Cutaneous Leiomyoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Male, run by Suleyman Demirel University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Hand and finger lengths (2d:4d) (time frame: Baseline (Day 0)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2026.